ARDIZZOIA, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 497
EU - Europa 190
AS - Asia 35
OC - Oceania 1
SA - Sud America 1
Totale 724
Nazione #
US - Stati Uniti d'America 494
IT - Italia 92
SE - Svezia 32
CN - Cina 27
DE - Germania 25
GB - Regno Unito 12
DK - Danimarca 8
AT - Austria 6
IE - Irlanda 4
UA - Ucraina 4
VN - Vietnam 4
CA - Canada 3
IN - India 3
RU - Federazione Russa 2
AU - Australia 1
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
FR - Francia 1
HU - Ungheria 1
RO - Romania 1
TR - Turchia 1
Totale 724
Città #
Ann Arbor 264
Wilmington 50
Fairfield 36
Milan 23
Chandler 21
Frankfurt am Main 21
Cambridge 16
Ashburn 15
Dearborn 15
Houston 13
Woodbridge 13
Seattle 9
Princeton 8
Hangzhou 7
Vienna 5
Altamura 4
Dong Ket 4
Dublin 4
Guangzhou 4
Lawrence 4
Perugia 3
Boardman 2
Cambiago 2
Cusano Milanino 2
Fremont 2
Hebei 2
Jacksonville 2
Nanchang 2
Ottaviano 2
Ottawa 2
Rovato 2
San Mateo 2
San Rocco 2
Seregno 2
Shenyang 2
Taizhou 2
Trieste 2
Verona 2
Andover 1
Beijing 1
Bergamo 1
Boston 1
Budapest 1
Chions 1
Châtillon 1
Edmonton 1
Huzhou 1
Jiaxing 1
Kiev 1
Kocaeli 1
Kunming 1
Laurel 1
Legnano 1
Lissone 1
London 1
Magnago 1
Marano di Napoli 1
Mountain View 1
Nanjing 1
Norwalk 1
Riano 1
Rome 1
San Diego 1
Sarego 1
Spello 1
Taiyuan 1
Tianjin 1
Trento 1
Turin 1
Zhengzhou 1
Totale 605
Nome #
Specific Expression of a New Bruton Tyrosine Kinase Isoform (p65BTK) in the Glioblastoma Gemistocytic Histotype 326
Multisite analysis of high-grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number alteration in 3q26.2 and 8q24.3 264
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 195
High-dose-rate brachytherapy as monotherapy for localized prostate cancer using three different doses - 14 years of single-centre experience 28
Treatment with gefitinib in elderly patients or patients with poor performance status (PS) affected with non small cell lung carcinoma (NSCLC) [Trattamento con Gefitinib nei pazienti anziani o con scarso performance status (PS), affetti da carcinoma polmonare non a piccole cellule (NSCLC)] 4
Totale 817
Categoria #
all - tutte 1168
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1168


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201970 0000 00 1113 961318
2019/2020227 16121117 1822 1733 2722302
2020/2021310 1213525 2637 3136 36272024
2021/2022103 1618208 03 16 57811
2022/2023107 9341412 316 66 7000
Totale 817